We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBRX icon
4876
Forte Biosciences
FBRX
$1.57B
$2.27K ﹤0.01%
100
-706
-88% -$8.4K
ACRE
4877
Ares Commercial Real Estate
ACRE
$259M
$2.27K ﹤0.01%
385
-9,153
-96% -$61.6K
IMG
4878
DELISTED
CIMG Inc
IMG
$2.26K ﹤0.01%
155
+3
+2% +$45
BDMD
4879
Baird Medical Investment Holdings
BDMD
$38.4M
$2.26K ﹤0.01%
+297
New +$820
BRTX icon
4880
BioRestorative Therapies
BRTX
$5.54M
$2.25K ﹤0.01%
1,577
-574
-27% -$888
UK icon
4881
Ucommune International Ltd Class A Ordinary Shares
UK
$1.38M
$2.25K ﹤0.01%
192
+162
+540% +$2K
SCHG icon
4882
Schwab US Large-Cap Growth ETF
SCHG
$63B
$2.23K ﹤0.01%
80
-44,224
-100% -$1.21M
TTOO
4883
DELISTED
T2 Biosystems, Inc
TTOO
$2.23K ﹤0.01%
5,304
+2,905
+121% +$2.43K
LRFC
4884
DELISTED
Logan Ridge Finance Corp
LRFC
$2.22K ﹤0.01%
+89
New +$2.21K
QNME
4885
Quanome Technologies, Inc. Common Stock
QNME
$17.2M
$2.21K ﹤0.01%
886
+191
+27% +$512
ULY
4886
DELISTED
Urgent.ly
ULY
$2.21K ﹤0.01%
362
-100
-22% -$709
TCRT icon
4887
Alaunos Therapeutics
TCRT
$4.84M
$2.19K ﹤0.01%
1,149
+509
+80% +$1.13K
BNBX
4888
DELISTED
BNB PLUS CORP
BNBX
$2.18K ﹤0.01%
14
CURI icon
4889
CuriosityStream
CURI
$165M
$2.18K ﹤0.01%
1,422
-681
-32% -$1.31K
PCSA icon
4890
Processa Pharmaceuticals
PCSA
$8.82M
$2.18K ﹤0.01%
98
-48
-33% -$1.35K
PHI icon
4891
PLDT
PHI
$4.24B
$2.17K ﹤0.01%
+98
New +$2.33K
JVSAU
4892
DELISTED
JVSPAC Acquisition Corp. Unit
JVSAU
$2.17K ﹤0.01%
200
PRPO icon
4893
Precipio
PRPO
$41.5M
$2.17K ﹤0.01%
391
-220
-36% -$1.35K
PICB icon
4894
Invesco International Corporate Bond ETF
PICB
$361M
$2.16K ﹤0.01%
100
SPTL icon
4895
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
$2.15K ﹤0.01%
+82
New +$2.25K
DYAI icon
4896
Dyadic International
DYAI
$37.9M
$2.15K ﹤0.01%
1,226
-2,518
-67% -$3.44K
BOLT icon
4897
Bolt Biotherapeutics
BOLT
$7.71M
$2.14K ﹤0.01%
200
+191
+2,122% +$2.31K
CNET icon
4898
ZW Data Action Technologies
CNET
$4.84M
$2.14K ﹤0.01%
+1,190
New +$2.26K
SLE icon
4899
Super League Enterprise
SLE
$4.79M
$2.14K ﹤0.01%
7
EAD
4900
Allspring Income Opportunities Fund
EAD
$379M
$2.14K ﹤0.01%
310

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.